| J9119 | Injection, cemiplimab-rwlc, 1 mg | 28,350 | $20 | $595.4K |
| J0897 | Injection, denosumab, 1 mg | 11,280 | $20 | $203.1K |
| J1568 | Injection, immune globulin, (octagam), intravenous, non-lyophilized (e.g., liquid), 500 mg | 4,720 | $30 | $155.8K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,310 | $90 | $114K |
| J2506 | Injection, pegfilgrastim, excludes biosimilar, 0.5 mg | 1,230 | $90 | $107.8K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 640 | $90 | $59.7K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 140 | $130 | $17.7K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 340 | $40 | $14.8K |
| 99205 | The provider sees a new patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the provider… | 90 | $150 | $13.1K |
| 96367 | The provider administers an additional intravenous infusion or infusions, after an initial infusion, of a different medication or substance for a period up to one hour to prevent, treat, or diagnose… | 510 | $20 | $10.6K |